Lactococcus lactis as a vehicle for the heterologous expression of fungal ribotoxin variants with reduced IgE-binding affinity

Journal of Biotechnology

Volumn 134, Issue 1-2, 2008, Pages 1-8

  Álvarez García, Elisa ^a   Alegre Cebollada, Jorge ^a   Batanero, Eva ^a   Monedero, Vicente ^b   Pérez Martínez, Gaspar ^b   García Fernández, Rosa ^a   Gavilanes, Jose G ^a   Martínez del Pozo, Álvaro ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Sarcin; Asp f 1; Probiotic; Ribonuclease

Indexed keywords

FUNGAL RIBOTOXINS; PROTEIN BIOSYNTHESIS; RIBONUCLEASE; RIBOSOMES;

BIOSYNTHESIS; CYTOTOXICITY; FUNGI; PH EFFECTS; PROTEINS; TOXIC MATERIALS;

BACTERIA;

ALPHA SARCIN; IMMUNOGLOBULIN E; PLASMID VECTOR; PROBIOTIC AGENT; PROTEIN ASP F 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; BINDING AFFINITY; CLONING VECTOR; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; FEMALE; HETEROLOGOUS EXPRESSION; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN SECRETION; PROTEIN VARIANT; WILD TYPE;

ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDORIBONUCLEASES; FEMALE; FUNGAL PROTEINS; GENETIC ENGINEERING; IMMUNOGLOBULIN E; INTESTINE, SMALL; LACTOCOCCUS LACTIS; MICE; MICE, INBRED BALB C; MYCOTOXINS; PLASMIDS; PROTEIN BINDING;

ASPERGILLUS GIGANTEUS; LACTOCOCCUS LACTIS; MUS;

EID: 39649092494     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2007.12.011     Document Type: Article

References (48)

1. Adel-Patient K., Ah-Leung S., Creminon C., Nouaille S., Chatel J.M., Langella P., and Wal J.M. Oral administration of recombinant Lactococcus lactis expressing bovine β-lactoglobulin partially prevents mice from sensitization. Clin. Exp. Allergy 35 (2005) 539-546
2. Banerjee B., and Kurup V.P. Molecular biology of Aspergillus allergens. Front. Biosci. 8 (2003) s128-s139
3. Barral P., Tejera M.L., Treviño M.A., Batanero E., Villalba M., Bruix M., and Rodríguez R. Recombinant expression of Ole e 6, a Cys-enriched pollen allergen, in Pichia pastoris yeast: detection of partial oxidation of methionine by NMR. Protein Expr. Purif. 37 (2004) 336-343
4. Blanquet S., Marol-Bonnin S., Beyssac E., Pompon D., Renaud M., and Alric M. The 'biodrug' concept: an innovative approach to therapy. Trends Biotechnol. 19 (2001) 393-400
5. Correll C.C., Wool I.G., and Munishkin A. The two faces of the Escherichia coli 23 S rRNA sarcin/ricin domain: the structure at 1.11 Å resolution. J. Mol. Biol. 292 (1999) 275-287
6. Corthier G., Delorme C., Ehrlich S.D., and Renault P. Use of luciferase genes as biosensors to study bacterial physiology in the digestive tract. Appl. Environ. Microbiol. 64 (1998) 2721-2722
7. Drouault S., Corthier G., Ehrlich S.D., and Renault P. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl. Environ. Microbiol. 65 (1999) 4881-4886
8. Endo Y., and Wool I.G. The site of action of α-sarcin on eukaryotic ribosomes. The sequence at the α-sarcin cleavage site in 28 S ribosomal ribonucleic acid. J. Biol. Chem. 257 (1982) 9054-9060
9. García-Mayoral M.F., García-Ortega L., Lillo M.P., Santoro J., Martínez del Pozo A., Gavilanes J.G., Rico M., and Bruix M. NMR structure of the noncytotoxic α-sarcin mutant Δ(7-22): the importance of the native conformation of peripheral loops for activity. Protein Sci. 13 (2004) 1000-1011
10. 2-terminal β-hairpin of the ribotoxin α-sarcin produces a non-toxic but active ribonuclease. J. Biol. Chem. 277 (2002) 18632-18639
11. García-Ortega L., Lacadena J., Villalba M., Rodríguez R., Crespo J.F., Rodríguez J., Pascual C., Olmo N., Oñaderra M., Martínez del Pozo A., and Gavilanes J.G. Production and characterization of a noncytotoxic deletion variant of the Aspergillus fumigatus allergen Asp f 1 displaying reduced IgE binding. FEBS J. 272 (2005) 2536-2544
12. Gil M.T., Pérez-Arellano I., Buesa J., and Pérez-Martínez G. Secretion of the rotavirus VP8* protein in Lactococcus lactis. FEMS Microbiol. Lett. 203 (2001) 269-274
13. Greenberger P.A. Allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 110 (2002) 685-692
14. Gruzza M., Fons M., Ouriet M.F., Duval-Iflah Y., and Ducluzeau R. Study of gene transfer in vitro and in the digestive tract of gnotobiotic mice from Lactococcus lactis strains to various strains belonging to human intestinal flora. Microb. Releases 2 (1994) 183-189
15. Hooper L.V., and Gordon J.I. Commensal host-bacterial relationships in the gut. Science 292 (2001) 1115-1118
16. Israelsen H., Madsen S.M., Vrang A., Hansen E.B., and Johansen E. Cloning and partial characterization of regulated promoters from Lactococcus lactis Tn917-lacZ integrants with the new promoter probe vector, pAK80. Appl. Environ. Microbiol. 61 (1995) 2540-2547
17. Kao R., Martínez-Ruiz A., Martínez del Pozo A., Crameri R., and Davies J. Mitogillin and related fungal ribotoxins. Methods Enzymol. 341 (2001) 324-335
18. Kirjavainen P.V., Apostolou E., Salminen S.J., and Isolauri E. New aspects of probiotics. A novel approach in the management of food allergy. Allergy 54 (1999) 909-915
19. Klijn N., Weerkamp A.H., and de Vos W.M. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 61 (1995) 2771-2774
20. Kurup V.P., Shen H.D., and Vijay H. Immunobiology of fungal allergens. Int. Arch. Allergy Immunol. 129 (2002) 181-188
21. Lacadena J., Martínez del Pozo A., Barbero J.L., Mancheño J.M., Gasset M., Oñaderra M., López-Otín C., Ortega S., García J.L., and Gavilanes J.G. Overproduction and purification of biologically active native fungal α-sarcin in Escherichia coli. Gene 142 (1994) 47-51
22. Lacadena J., Mancheño J.M., Martínez-Ruiz A., Martínez del Pozo A., Gasset M., Oñaderra M., and Gavilanes J.G. Substitution of histidine-137 by glutamine abolishes the catalytic activity of the ribosome-inactivating protein α-sarcin. Biochem. J. 309 (1995) 581-586
23. Lacadena J., Martínez del Pozo A., Martínez-Ruiz A., Pérez-Cañadillas J.M., Bruix M., Mancheño J.M., Oñaderra M., and Gavilanes J.G. Role of histidine-50, glutamic acid-96 and histidine-137 in the ribonucleolytic mechanism of the ribotoxin α-sarcin. Proteins 37 (1999) 474-484
24. Lacadena J., Álvarez-García E., Carreras-Sangrà N., Herrero-Galán E., Alegre-Cebollada J., García-Ortega L., Oñaderra M., Gavilanes J.G., and Martínez del Pozo A. Fungal ribotoxins: molecular dissection of a family of natural killers. FEMS Microbiol. Rev. 31 (2007) 212-237
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
26. Maassen C.B. A rapid and safe plasmid isolation method for efficient engineering of recombinant lactobacilli expressing immunogenic or tolerogenic epitopes for oral administration. J. Immunol. Methods 223 (1999) 131-136
27. Maassen C.B., Laman J.D., den Bak-Glashouwer M.J., Tielen F.J., van Holten-Neelen J.C., Hoogteijling L., Antonissen C., Leer R.J., Pouwels P.H., Boersma W.J., and Shaw D.M. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine 17 (1999) 2117-2128
28. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
29. Martínez del Pozo A., Gasset M., Oñaderra M., and Gavilanes J.G. Conformational study of the antitumor protein α-sarcin. Biochim. Biophys. Acta 953 (1988) 280-288
30. Moser M., Crameri R., Menz G., Schneider T., Dudler T., Virchow C., Gmachl M., Blaser K., and Suter M. Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. J. Immunol. 149 (1992) 454-460
31. Nouaille S., Ribeiro L.A., Miyoshi A., Pontes D., Le Loir Y., Oliveira S.C., Langella P., and Azevedo V. Heterologous protein production and delivery systems for Lactococcus lactis. Genet. Mol. Res. 2 (2003) 102-111
32. Olmo N., Turnay J., González de Buitrago G., López de Silanes I., Gavilanes J.G., and Lizarbe M.A. Cytotoxic mechanism of the ribotoxin α-sarcin. Induction of cell death via apoptosis. Eur. J. Biochem. 268 (2001) 2113-2123
33. Olson B.H., Jennings J.C., Roga V., Junek A.J., and Schuurmans D.M. α-Sarcin, a new antitumor agent. II. Fermentation and antitumor spectrum. Appl. Microbiol. 13 (1965) 322-326
34. O'Sullivan D.J., and Klaenhammer T.R. Rapid mini-prep isolation of Hhgh-quality plasmid DNA from Lactococcus and Lactobacillus spp. Appl. Environ. Microbiol. 59 (1993) 2730-2733
35. Perez C.A., Eichwald C., Burrone O., and Mendoza D. Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice. J. Appl. Microbiol. 99 (2005) 1158-1164
36. Pérez-Cañadillas J.M., Santoro J., Campos-Olivas R., Lacadena J., Martínez del Pozo A., Gavilanes J.G., Rico M., and Bruix M. The highly refined solution structure of the cytotoxic ribonuclease α-sarcin reveals the structural requirements for substrate recognition and ribonucleolytic activity. J. Mol. Biol. 299 (2000) 1061-1073
37. 15N NMR relaxation methods. J. Biomol. NMR 24 (2002) 301-316
38. Pouwels P.H., Leer R.J., and Boersma W.J. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J. Biotechnol. 44 (1996) 183-192
39. Robinson K., Chamberlain L.M., Schofield K.M., Wells J.M., and Le Page R.W. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15 (1997) 653-657
40. Roga V., Hedeman L.P., and Olson B.H. Evaluation of mitogillin (NSC-69529) in the treatment of naturally occurring canine neoplasms. Cancer Chemother. Rep. 55 (1971) 101-113
41. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual. 3rd edn. (2001), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
42. Schiffrin E.J., and Blum S. Food processing: probiotic microorganisms for beneficial foods. Curr. Opin. Biotechnol. 12 (2001) 499-502
43. Schindler D.G., and Davies J.E. Specific cleavage of ribosomal RNA caused by α-sarcin. Nucleic Acids Res. 4 (1977) 1097-1110
44. Schotte L., Steidler L., Vandekerckhove J., and Remaut E. Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme Microb. Technol. 27 (2000) 761-765
45. Steidler L., Wells J.M., Raeymaekers A., Vandekerckhove J., Fiers W., and Remaut E. Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 61 (1995) 1627-1629
46. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., and Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 (2000) 1352-1355
47. Villalba M., Batanero E., Monsalve R.I., González de la Peña M.A., Lahoz C., and Rodríguez R. Cloning and expression of Ole e I, the major allergen from olive tree pollen. Polymorphism analysis and tissue specificity. J. Biol. Chem. 269 (1994) 15217-15222
48. Xin K.Q., Hoshino Y., Toda Y., Igimi S., Kojima Y., Jounai N., Ohba K., Kushiro A., Kiwaki M., Hamajima K., Klinman D., and Okuda K. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV. Env. Blood 102 (2003) 223-228